Multi-Center Validation of an Artificial Intelligence-Enabled ECG Model to Predict 1-Year Risk of Atrial Fibrillation or Flutter

BACKGROUND: Atrial fibrillation (AF) is the most common cardiac arrhythmia associated with an increased risk of stroke and heart failure. AF is often asymptomatic and paroxysmal, making diagnosis challenging. Artificial intelligence (AI) applied to electrocardiogram (ECG) interpretation is a promising approach for improved diagnosis. Although ECG-AI studies have shown promise, the common practice of evaluating based on data from single institutions may overestimate performance. External validation is essential to ensure that AI models generalize well to diverse settings and populations. OBJECTIVE: This study aimed to externally validate an ECG-AI model for predicting 1-year AF risk. METHODS: In this retrospective study, ECG data from 3 clinical sites were aggregated and patients' charts were manually abstracted to define inclusion and exclusion criteria (age 65+ years with no previous AF or history of pacer/defibrillator use) and endpoints (new AF diagnosis within 1 year or 1 year of AF-free follow-up). The sensitivity and specificity of a risk score from an ECG-AI model were evaluated against prespecified minimum values of 20% and 85%, respectively. RESULTS: The analysis included 4017 patients, with 240 (6.0%) developing AF within 1 year. The ECG-AI model returned an "increased risk" result for 391 patients (9.7%), including 74 who developed AF (sensitivity 31%; 95% confidence interval 25-37). A total of 3626 patients had a "no increased risk" result, with 3460 remaining free from AF (specificity 92%; 95% confidence interval 91-92). CONCLUSION: The results validate the performance of the Tempus ECG-AF model and support its clinical use for AF risk stratification.

Authors

Institutions

Publication Details

Journal
Heart Rhythm
Published
2026-04-01
DOI
https://doi.org/10.1016/j.hrthm.2026.03.1956
Primary Topic
ECG Monitoring and Analysis
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Multi-Center Validation of an Artificial Intelligence-Enabled ECG Model to Predict 1-Year Risk of Atrial Fibrillation or Flutter

Christopher M. Haggerty, Arun Nemani, John M. Pfeifer, Gargi Schneider et al.
Heart Rhythm
ECG Monitoring and Analysis
article

Multi-Center Validation of an Artificial Intelligence-Enabled ECG Model to Predict 1-Year Risk of Atrial Fibrillation or Flutter

Christopher M. Haggerty, Arun Nemani, John M. Pfeifer, Gargi Schneider, Sushravya Raghunath, David Kao, Farahnaz Islam, Emma Hovanec, Alain D. Silk, Thomas Morland, Ruijun Chen, Seung Won Hyun, Larry Hui, Greg Lee, Thomas Boyden, Joseph Banno, Elani Kaufman, Brandon K. Fornwalt, Merrit Pogue, Taylor Green, Michael Jones
article en

Abstract

BACKGROUND: Atrial fibrillation (AF) is the most common cardiac arrhythmia associated with an increased risk of stroke and heart failure. AF is often asymptomatic and paroxysmal, making diagnosis challenging. Artificial intelligence (AI) applied to electrocardiogram (ECG) interpretation is a promising approach for improved diagnosis. Although ECG-AI studies have shown promise, the common practice of evaluating based on data from single institutions may overestimate performance. External validation is essential to ensure that AI models generalize well to diverse settings and populations. OBJECTIVE: This study aimed to externally validate an ECG-AI model for predicting 1-year AF risk. METHODS: In this retrospective study, ECG data from 3 clinical sites were aggregated and patients' charts were manually abstracted to define inclusion and exclusion criteria (age 65+ years with no previous AF or history of pacer/defibrillator use) and endpoints (new AF diagnosis within 1 year or 1 year of AF-free follow-up). The sensitivity and specificity of a risk score from an ECG-AI model were evaluated against prespecified minimum values of 20% and 85%, respectively. RESULTS: The analysis included 4017 patients, with 240 (6.0%) developing AF within 1 year. The ECG-AI model returned an "increased risk" result for 391 patients (9.7%), including 74 who developed AF (sensitivity 31%; 95% confidence interval 25-37). A total of 3626 patients had a "no increased risk" result, with 3460 remaining free from AF (specificity 92%; 95% confidence interval 91-92). CONCLUSION: The results validate the performance of the Tempus ECG-AF model and support its clinical use for AF risk stratification.

Heart Rhythm
Tempus Labs (United States) (US), Corewell Health, University of Colorado Anschutz Medical Campus (US), Geisinger Commonwealth School of Medicine (US)
Openalex Percentile: Top 29%
ECG Monitoring and Analysis
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.